What is the appropriate systemic chemotherapy for lymphocyte-predominant Hodgkin's lymphoma?

J Clin Oncol. 2010 Jan 1;28(1):e8. doi: 10.1200/JCO.2009.26.3293. Epub 2009 Nov 23.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Agents, Alkylating / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Hodgkin Disease / drug therapy*
  • Hodgkin Disease / pathology
  • Humans
  • Lymphocytes / pathology*

Substances

  • Antineoplastic Agents, Alkylating